Plasticell Delivers Differentiation Protocols to Stemnion, Inc.

Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced the successful completion of a collaboration with Stemnion, Inc. (Pittsburgh, PA), a US biotechnology company focused on the applications of stem cells derived from human placentas. Plasticell used its flagship technology CombiCult™ to discover multiple novel, serum-free protocols that direct the differentiation of Stemnion’s [...]

August 3rd, 2011|Press Releases|

Plasticell‘s CombiCult™ v2.0 platform wins international R&D 100 Award

Plasticell’s high throughput screen for stem cell differentiation joins list of the most significant technology products developed globally in the last 49 years Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has won the prestigious R&D 100 Award for its CombiCult™v2.0 system. The CombiCult™ platform is a high-throughput combinatorial screening technology that allows scientists [...]

June 23rd, 2011|Press Releases|

Plasticell Spins Out Regenerative Drug Discovery Venture

New demerged business called ‘Progenitor Labs’ Plasticell Ltd, the biotechnology company developing high throughput stem cell technologies, has announced today that following its recent £3.5m financing, it has undergone a strategic re-structuring to enable the Company to focus on its award winning CombiCult™ technology for stem cell differentiation. Consequently, Plasticell Ltd has demerged its regenerative drug discovery unit into a [...]

April 13th, 2011|Press Releases|

Plasticell completes £3.5 million financing round

Capital injection to expand business development and marketing initiatives Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced it has completed a two-part equity financing, raising a total of £3.5 million from new and existing investors. The first tranche of the financing, in which £1.5 million was drawn down in April 2009, was [...]

January 31st, 2011|Press Releases|

Plasticell signs technology agreement with Sigma-Aldrich

Collaboration to produce novel turnkey solution for stem cell research Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced the signing of a collaboration agreement with Sigma-Aldrich, a leading provider of technologies and reagents to the life science research market. In the collaboration, Sigma-Aldrich will use its CompoZr® Zinc Finger Nuclease Technology to [...]

November 29th, 2010|Press Releases|

Plasticell signs screening collaboration with UCB. First in kind deal to partner small molecule drugs for stem cell research

Plasticell, the biotechnology company specialising in the use of innovative high throughput technologies in stem cell research, has announced signing of a collaboration agreement with the biopharmaceutical company, UCB. Under the terms of the agreement, UCB will supply Plasticell with drug compound libraries with known biological targets. Plasticell will screen these using its award-winning CombiCult technology to discover new cell [...]

November 8th, 2010|Press Releases|

Plasticell validates regenerative drug screen in collaboration with GSK

London, 12 March 2009 … Research announced today by Plasticell, a leading UK regenerative medicine biotech company, shows how embryonic stem cells can be used to discover novel small molecules capable of encouraging the body to regenerate, potentially paving the way for the development of drugs to repair organs damaged by disease or ageing. Plasticell used its proprietary technologies to [...]

March 12th, 2009|Press Releases|

Plasticell funds two Industrial Collaborations with University College London

London, UK, 15 January 2009. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, today announced that it is funding industrial collaborative projects in two separate laboratories based in University College London (UCL). The first collaboration, with the groups of Professors Chris Mason and Nigel Titchener-Hooker, of the UCL Advanced Centre for Biochemical Engineering, will result [...]

January 15th, 2009|Press Releases|

Plasticell obtains investment from TSB Technology Programme

London, UK, 1 October 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced it has received further funding from the Technology Strategy Board (TSB; formerly part of DTI) to apply its technologies towards developing a novel cell therapy designed to stimulate and sustain tissue regeneration. Plasticell is part of a consortium, additionally comprising [...]

October 1st, 2008|Press Releases|

Plasticell publication describes combinatorial methods in stem cell research

London, UK, 1 August 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced the publication of a book chapter which presents the case for combinatorial methods in stem cell research. The chapter by Dr. Yen Choo, Plasticell’s founder, is entitled ‘Use of Combinatorial Screening to Discover Protocols That Effectively Direct the Differentiation of [...]

August 1st, 2008|Press Releases|